Neurology (43 companies · 53 conditions)

Conditions

Major Depressive Disorder 9 Parkinson's Disease 7 Alzheimer's Disease 6 Amyotrophic Lateral Sclerosis 6 Rare Bipolar Disorder 5 Generalized Anxiety Disorder 5 Duchenne Muscular Dystrophy 4 Rare Friedreich's Ataxia 4 Rare Myasthenia Gravis 4 Rare Epilepsy 3 Huntington's Disease 3 Rare Lewy Body Dementia 3 Multiple Sclerosis 3 Post-Traumatic Stress Disorder 3 Schizophrenia 3 Substance Use Disorder 3 Facioscapulohumeral Muscular Dystrophy 2 Rare Frontotemporal Dementia 2 Rare Ischemic Stroke 2 Myotonic Dystrophy 2 Rare Acute Pain 1 Aneurysmal Subarachnoid Hemorrhage 1 Angelman Syndrome 1 Rare Anorexia Nervosa 1 Ataxia-Telangiectasia 1 Rare Attention Deficit Hyperactivity Disorder 1 Autism Spectrum Disorder 1 Charcot-Marie-Tooth Disease Type 2S 1 Rare Chronic Inflammatory Demyelinating Polyneuropathy 1 Rare CLN2 Batten Disease 1 Rare Cocaine Use Disorder 1 Delayed Sleep Phase Disorder 1 Fragile X Syndrome 1 Rare GNE Myopathy 1 Rare Guillain-Barré Syndrome 1 Infantile Spasms 1 Rare Insomnia 1 Jet Lag Disorder 1 Limb-Girdle Muscular Dystrophy 1 Rare Migraine 1 Multiple System Atrophy 1 Rare Non-24-Hour Sleep-Wake Disorder 1 Non-Fluent Variant Primary Progressive Aphasia 1 Rare Postherpetic Neuralgia 1 Progressive Supranuclear Palsy 1 Rare Rett Syndrome 1 Rare Smith-Magenis Syndrome 1 Rare Spinal and Bulbar Muscular Atrophy 1 Rare Spinal Bulbar Muscular Atrophy 1 Rare Spinal Cord Injury 1 Stiff Person Syndrome 1 Rare Tuberous Sclerosis Complex 1 Rare X-Linked Adrenoleukodystrophy 1 Rare

Companies

Ticker	Company	Therapeutic areas	In Neurology	Lead stage	Programs
ABOS	Acumen Pharmaceuticals	Neurology	2	Phase 2	2
ATHE	ALTERITY THERAPEUTICS LTD	Neurology Rare	2	Phase 2	2
ALT	Altimmune, Inc.	GI/HepatologyMetabolicNeurology	1	Phase 2	3
AMLX	Amylyx Pharmaceuticals, Inc.	MetabolicNeurology Rare	1	Phase 3	5
ANNX	Annexon, Inc.	HematologyNeurologyOphthalmologyRenal Rare	3	NDA Submitted	6
ARVN	ARVINAS, INC.	NeurologyOncology Rare	4	Approved	15
ATAI	AtaiBeckley Inc.	Neurology	5	Phase 3	5
CABA	Cabaletta Bio, Inc.	DermatologyImmunologyNeurologyRenal Rare	1	Phase 1	8
CRVO	CervoMed Inc.	Neurology Rare	5	Phase 2	5
CLNN	Clene Inc.	Neurology Rare	3	NDA Submitted	5
CGTX	COGNITION THERAPEUTICS INC	NeurologyOphthalmology	2	Phase 2	2
CMPS	COMPASS Pathways plc	Neurology	3	NDA Submitted	3
HELP	CYBIN INC.	Neurology	4	Phase 2	4
DFTX	Definium Therapeutics, Inc.	Neurology	4	Phase 3	4
DYN	Dyne Therapeutics, Inc.	MetabolicNeurology Rare	7	Phase 3	10
EVMN	Evommune, Inc.	DermatologyImmunologyNeurology	1	Phase 2	6
GANX	Gain Therapeutics, Inc.	MetabolicNeurology Rare	4	Phase 1	5
GHRS	GH Research PLC	NeurologyWomen's Health	3	Phase 2	4
GRCE	Grace Therapeutics, Inc.	Neurology Rare	3	Phase 3	3
IMVT	Immunovant, Inc.	ImmunologyNeurology Rare	2	Phase 2	6
IXHL	Incannex Healthcare Inc.	ImmunologyNeurologyRespiratory	1	Phase 2	3
KYTX	Kyverna Therapeutics, Inc.	ImmunologyNeurologyRenal Rare	3	NDA Submitted	7
LRMR	Larimar Therapeutics, Inc.	Neurology Rare	1	Phase 3	1
LXEO	Lexeo Therapeutics, Inc.	CardiovascularNeurology Rare	5	Phase 1	10
LGVN	Longeveron Inc.	CardiovascularMetabolicNeurology Rare	1	Phase 2	4
NGEN	NERVGEN PHARMA CORP.	Neurology	2	Preclinical	2
NRXP	NRX Pharmaceuticals, Inc.	Neurology	5	NDA Submitted	5
OMER	OMEROS CORP	HematologyNeurologyOncologyRespiratory Rare	2	NDA Submitted	7
OVID	Ovid Therapeutics Inc.	Neurology Rare	3	Phase 1	6
KTTA	Pasithea Therapeutics Corp.	NeurologyOncology	1	Phase 1	3
RVPH	REVIVA PHARMACEUTICALS HOLDINGS, INC.	CardiovascularDermatologyNeurologyRespiratory Rare	6	Phase 3	10
SRPT	Sarepta Therapeutics, Inc.	Neurology Rare	10	Approved	10
SLDB	Solid Biosciences Inc.	CardiovascularNeurology Rare	2	Phase 3	6
SPRB	SPRUCE BIOSCIENCES, INC.	MetabolicNeurology Rare	0	Preclinical	2
TSHA	Taysha Gene Therapies, Inc.	Neurology Rare	2	Phase 3	3
RARE	Ultragenyx Pharmaceutical Inc.	CardiovascularGI/HepatologyMetabolicNeurology Rare	2	Approved	12
QURE	uniQure N.V.	HematologyMetabolicNeurology Rare	4	Approved	6
VNDA	Vanda Pharmaceuticals Inc.	CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare	14	Approved	26
VKTX	Viking Therapeutics, Inc.	GI/HepatologyMetabolicNeurology Rare	1	Phase 3	9
VOR	Vor Biopharma Inc.	ImmunologyNeurologyOncology Rare	1	Phase 3	4
VYGR	Voyager Therapeutics, Inc.	MetabolicNeurology Rare	6	Phase 1	7
WVE	Wave Life Sciences Ltd.	MetabolicNeurologyRespiratory Rare	2	Phase 2	5
XENE	Xenon Pharmaceuticals Inc.	Neurology	9	Phase 3	9